Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyAlimentary Pharmacology & Therapeutics (Suppl), 2020, 52 (3), pp.500-512. ⟨10.1111/apt.15901⟩
Journal articles
hal-03933002v1
|
||
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in FranceDigestive Diseases and Sciences, 2021, 66 (3), pp.881-898. ⟨10.1007/s10620-020-06234-1⟩
Journal articles
hal-03228797v1
|